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Retinoids, a  group of naturally occurring lipid molecules structurally related 
to Vitamin  A  (trans-retinol),  exert profound effects on the growth and  differ- 
entiation of a wide variety of cells and tissues (1). Myeloid cells in particular seem 
to be targets of retinoid action. The differentiation of both normal and leukemic 
myeloid cells can be altered by exposure of the cells to retinoids, and it has been 
suggested that retinoids may play a physiological role in regulating the terminal 
maturation of these cells (2). In spite of the potential importance of retinoids as 
regulators  of myeloid  cell  development,  little  information  is  available  on  the 
molecular mechanisms  that are involved in  this process.  Recently we reported 
that  retinoids  can  dramatically  increase  the  synthesis  of  the  enzyme  tissue 
transglutaminase in both normal and leukemic myeloid cells (3, 4), and activation 
of macrophages also leads  to marked induction of the enzyme (5).  We believe 
that the induction of tissue transglutaminase  is a  marker of myeloid cell differ- 
entiation and a valuable tool for studying the molecular basis of retinoid action. 
To further our understanding of the mechanisms involved in retinoid action in 
myeloid cells, we have investigated the effects of all-trans-retinoic acid (retinoic 
acid) on the  levels of tissue transglutaminase  mRNA  in both mouse peritoneal 
macrophages and human promyelocytic leukemia (HL-60) cells. We report here 
that in both of these cell types, retinoic acid induces a  dramatic increase in the 
levels of tissue  transglutaminase  mRNA  within  30  min.  These studies  provide 
experimental confirmation for the proposition that  retinoids can  induce acute 
and specific alterations in gene expression in both normal and malignant myeloid 
cells. 
Materials and Methods 
ICR strain adult male mice were obtained from Harlan Sprague-Dawley, Inc. (Houston, 
TX). HL-60 cells adapted to grow in serum-free media were cultured under conditions 
described previously (4). Retinoic acid was a gift of Hoffman-LaRoche Inc., (Nutley, N  J). 
CsCl,  dibutyryl cyclic AMP (Bt~cAMP),  insulin,  transferrin, and  sodium selenite were 
purchased  from  Sigma  Chemical  Co.  (St.  Louis,  MO).  Delipidized mouse  serum  was 
prepared as described previously (3).  Oligo-dT-cellulose was purchased from Bethesda 
Research Laboratories (Bethesda,  MD).  RPMI  1640 media was purchased from Gibco 
Laboratories (Grand Island, NY). A reticulocyte lysate translation kit and [~SS]methionine 
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were purchased from New England Nuclear (Boston, MA). [~4C]amino acids were from 
Becton-Dickinson Immunodiagnostics (Orangeburg,  NY).  The  properties  of the  goat 
anti-tissue transglutaminase antibodies used in these studies have been reported previously 
(5). 
Isolation  of RNA and In  Vitro Translation.  Mouse resident peritoneal macrophages, 
isolated by peritoneal lavage and attachment to plastic  tissue culture dishes (5), were 
cultured in RPMI 1640 media and 2% delipidized mouse serum in the presence or absence 
of 1 ~M  retinoic acid.  HL-60 cells  were  grown in suspension culture in  RPMI  1640 
medium supplemented with sodium selenite (3 nM), insulin (5 t~g/ml), and transferrin (5 
ttg/ml). Tissue transglutaminase was induced by the addition of 1 mM BtzcAMP and  1 
#M retinoic acid. 
To isolate macrophage RNA, cell monolayers were washed three times with PBS, and 
solubilized in the iysis  buffer described by Chirgwin et al (6). Total RNA was then isolated 
by C~CI gradient centrifugation (6). Polyadenylated macrophage RNA was prepared from 
2 x  109 resident peritoneal macrophages (1,150 mice) incubated 6 h in medium containing 
1 uM retinoic acid. Total RNA (1.6 rag) was chromatographed on oligo-dT-cellulose (7). 
Total RNA was isolated from HL-60 cells grown in suspension culture. Cell pellets were 
washed three  times in  PBS  and  lysed in  7  M guanidine HCI.  DNA  was removed by 
differential  precipitation  from  ethanol  and  proteins  were  extracted  with  chloro- 
form/isobutanol (4:1). RNA was purified by differential precipitation (6), and polyaden- 
ylated RNA was obtained by oligo-dT cellulose chromatography (7). 
Total RNA and polyadenylated RNA were translated using a commercial reticulocyte 
lysate kit containing [~S]methionine. The translation products were either solubilized 
directly in SDS-containing gel mix, or they were immunoprecipitated by the addition of 
5 ug of affinity-purified  goat anti-guinea pig tissue transglutaminase to a solution contain- 
ing the translation mixture (4 x  104 cpm for macrophage translations, 106 cpm for HL- 
60 translations). Immunoprecipitated proteins were solubilized with SDS-gel mix, frac- 
tionated by SDS-gel electrophoresis on 6.5% discontinuous polyacrylamide slab gel, and 
identified by fluorography as described previously (5). 
Results 
To observe the effect of retinoic acid on tissue transglutaminase mRNA levels 
in mouse peritoneal macrophages, cells were cultured for 6 h in the presence or 
absence of 1 t~M retinoic acid. Total RNA was then isolated from the cells and 
translated in vitro. The two bands in the control without RNA (Fig.  1, lane 1) 
are due to the nonenzymatic coupling of methionine to reticulocyte proteins (8). 
Translation of macrophage RNA resulted in the synthesis of numerous polypep- 
tides, most of which were equivalent in the samples obtained from either control 
or retinoic acid-treated cell RNA (Fig. 1, lane 2 vs. lane 3). Three new bands, at 
78,  41, and  38  kD, were prominent in the translation products of RNA  from 
the retinoic acid-treated cells. The 78-kD band had an electrophoretic mobility 
very similar to purified guinea pig tissue transglutaminase and was specifically 
immunoprecipitated by an anti-tissue transglutaminase antibody (lanes 4 and 5). 
The other two retinoic acid-induced bands, at 41 and 38 kD, were not precipi- 
tated by the anti-tissue transglutaminase antibodies.  Polyadenylated RNA, pu- 
rified  from  retinoic  acid-treated  macrophages  and  translated  in  vitro,  also 
showed a prominent 78 kD-band that was immunoprecipitated by the anti-tissue 
transglutaminase antibodies (Fig. 1, lanes 6 and 7). 
To determine if retinoic acid also induced tissue transglutaminase mRNA in 
HL-60 cells, polyadenylated RNA was purified from untreated and retinoic acid- 
treated  HL-60  cells  and  translated  in  vitro.  Tissue  transglutaminase  was  not 
detected in the total translation products of control cell RNA (Fig.  1, lane 8) or 
its  immunoprecipitate  (Fig.  1,  lane  9).  However,  the  translation  products  of MURTAUGH  ET  AL.  BRIEF  DEFINITIVE  REPORT  1327 
FIGURE  1.  In vitro translation of RNA from retinoic acid-treated macrophages and HL-60 
cells. (A)  Mouse peritoneal  macrophages  were cultured  for 6  h  in  RPMI  medium plus 2% 
delipidized serum alone (control) or with  1 #M retinoic acid (RA-treated). RNA was isolated 
from the cells, translated using a reticulocyte lysate and [sSS]methionine. The total translation 
products from a blank without RNA (lane 1), control cell RNA (lane 2), and RA-treated cell 
RNA (lane 3) were solubilized in SDS-gel mix and fractionated on a 6.5% polyacrylamide slab 
gel. Translation products from control cell and RA-treated cell RNA were also immunopre- 
cipitated with an antibody to tissue transglutaminase (lanes 4 and 5 respectively). (B) Polyaden- 
ylated RNA, purified from RA-treated macrophages,  was translated and either fractionated 
on a 6.5% polyacrylamide slab gel (lane 6) or immunoprecipitated with an anti-tissue trans- 
glutaminase antibody (lane 7).  (C) HL-60 cells were cultured for 18 h  in media containing 1 
mM Bt2cAMP (control) or 1 #M retinoic acid and 1 mM Bt~cAMP (RA-treated). Polyadenylated 
RNA from control and RA-treated cells was translated and then either electrophoresed on a 
10%  SDS-acrylamide gel (lanes 8  and  10) or immunoprecipitated  with anti-tissue transglu- 
taminase antibody (lanes 9 and 11). Arrows, mobility of purified tissue transglutaminase. 
retinoic acid-treated cell RNA revealed a  band at 82  kD (lane 10, arrow) that 
was immunoprecipitated by anti-tissue transglutaminase IgG (Fig. 1, lane I 1). 
To follow the time course for the induction of tissue transglutaminase mRNA, 
resident peritoneal macrophages were exposed to 1 uM retinoic acid for various 
lengths  of time;  total  RNA  was  isolated,  translated  in  vitro,  and  the  tissue 
transglutaminase  immunoprecipitated  (Fig.  2A).  In  untreated  cells  and  cells 
treated for up to 30 min with retinoic acid (Fig. 2, lanes 1 and 2, respectively), 
the levels of tissue transglutaminase mRNA were very low. Cells treated for >30 
min, however, showed increasing accumulation of tissue transglutaminase mRNA 
as  indicated by an  increasingly intense band  of tissue  transglutaminase in  the 
immunoprecipitates (lanes 3-6).  Quantitation of the transglutaminase band by 
densitometry indicated a linear increase in the levels of transglutaminase mRNA 
that started ~30 min after the addition of the retinoid (Fig. 2B). 
To determine if there was posttranslational processing of tissue transglutamin- 
ase in myeloid cells, we compared the electrophoretic mobility of tissue transglu- 
taminase synthesized in vitro with that immunoprecipitated from metabolically 1328  MURTAUGH  ET  AL.  BRIEF  DEFINITIVE  REPORT 
FIGtSR~ 2.  Time  course  for  retinoic acid-induced expression  of tissue  transglutaminase 
mRNA in cultured mouse peritoneal macrophages. (A) Mouse peritoneal macrophages were 
cultured in medium containing 1 #M retinoic acid for 0  (lane 1), 0.5 (lane 2),  1 (lane 3), 2 
(lane 4), 4 (lane 5) and 6 h (lane 6). Total RNA was isolated, translated, and immunoprecipi- 
tated with an anti-transglutaminase  antibody and then fractionated on a  10% polyacrylamide 
slab gel.  Macrophages cultured with retinoic acid for 5 h  also were pulse-labeled with [ssS] 
cysteine and a cell lysate prepared in SDS was electrophoresed in lane 7. (B) The densities of 
the tissue transglutaminase bands in lanes 1-6 were quantified by laser densitometry. 
labeled cells (Fig. 3). Immunoprecipitates from metabolically labeled HL-60 cells 
showed a major band of tissue transglutaminase  at 82 kD (Fig.  3, arrow). Tissue 
transglutaminase synthesized from HL-60 cell RNA had the same electrophoretic 
mobility  (lane  2).  A  mixture  of equal  amounts  of the  metabolically  labeled 
protein and the protein synthesized in vitro gave a single band (lane 3). Similar 
results were obtained with mouse macrophage  transglutaminase  synthesized in 
vitro and in vivo (Fig. 2A, lanes 6 and 7). These results show that neither human 
nor  mouse tissue transglutaminase  are subjected to extensive posttranslational 
processing. 
Discussion 
It is often assumed that retinoids,  like steroid hormones,  have their primary 
effect at the level of the genome, regulating the expression of specific proteins 
(9).  However,  at  present  there  is  little  experimental  evidence  that  retinoids 
directly regulate gene expression.  Retinoids alter the expression of a  variety of 
cellular proteins  in a  number of different cultured  cell  lines (1,  10),  but these 
effects are generally  the result of chronic  exposure to retinoids.  Such chronic 
effects may reflect secondary consequences of retinoid-induced  differentiation 
rather than a primary effect of the retinoid on gene expression itself. Our results 
provide more direct evidence that, at least in myeloid cells, retinoids can induce 
acute alterations in gene expression.  Increased levels of tissue transglutaminase 
mRNA  were detected  30  rain  or  more  after  the  addition  of retinoic  acid  to 
cultured macrophages.  Given the relatively insensitive assay techniques we have MURTAUGH  ET  AL.  BRIEF  DEFINITIVE  REPORT  1329 
FIGURE 3.  Comparison  of HL-60  cell  tissue transglutaminase synthesized in  vitro and  in 
intact cells. HL-60 cells were incubated for 18 h in medium containing 1 t~M retinoic acid and 
1 mM Bt~cAMP, and either [t4C]amino acids or RNA was isolated from the cells and translated 
in vitro. Tissue transglutaminase was immunoprecipitated from the metabolically labeled cell 
extract (lane 1, arrow) or the in vitro translation reaction mix (lane 2). Lane 3 shows a mixture 
of equal amounts of tissue transglutaminase from metabolically labeled cells and the in vitro 
translation reaction. 
used and the time required  for mature  mRNA molecules to accumulate in the 
cytoplasm, our results suggest that altered gene expression follows very rapidly 
the addition of retinoids to macrophages. 
The extent of transglutaminase  induction  in macrophages and HL-60 cells is 
remarkable. Our previous studies have shown that fresh serum or retinoids cause 
the enzyme to accumulate up to  1% of total cellular protein in 24 h  (3-5). This 
enormous  induction  appears  to  be  due  to  a  very  large  induction  of  tissue 
transglutaminase mRNA. In unstimulated macrophages, the level of tissue trans- 
glutaminase  mRNA  is  low.  In  retinoid-treated  cells,  on  the  other  hand,  the 
enzyme can easily be identified in the translation  products without the need for 
immunoprecipitation, suggesting that tissue transglutaminase mRNA has become 
one of the most abundant mRNA in the cell. 
It  has  long  been  recognized  that  a  nutritional  deficiency  in  vitamin  A  is 
associated with a significant impairment of immune function (11). Although the 
cellular basis for this dysfunction is not known, the high incidence of generalized 
infections and decreased efficacy of tumor cell killing in retinoid-deficient animals 
suggests  that  macrophage  function  may be suppressed  (11).  Our  finding  that 
physiological levels of retinoids can have profound effects on gene expression in 1330  MURTAUGH  ET  AL.  BRIEF  DEFINITIVE  REPORT 
macrophages  supports  the  idea  that  these  metabolites  of vitamin  A  may  be 
important regulators of immune function. 
Summary 
Retinoic acid has been shown to induce large accumulations of tissue transglu- 
taminase in cultured myeloid cells. Addition of retinoic acid to mouse resident 
peritoneal  macrophages  increased  the  level of tissue  transglutaminase  mRNA 
within  30-60  min.  Retinoic acid also increased tissue transglutaminase  mRNA 
levels in human promyelocytic leukemia (HL-60) cells. These studies show that 
retinoic acid  can  induce acute  alterations  in  specific  gene  expression  in  both 
normal and leukemic myeloid cells. 
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